Please use this identifier to cite or link to this item:
|Title:||Antimycobacterial compounds. Optimization of the BM212 structure, the lead compound for a new pyrrole derivative class||Authors:||Biava, M
|Keywords:||Antimycobacterial activity; Pharmacophore model; Pyrrole derivatives; , Thiomorpholinomethyl substituent||Issue Date:||2005||Project:||None||Journal:||BIOORGANIC & MEDICINAL CHEMISTRY||Abstract:||
Our work on antitubercular agents led to the identification of BM 212 as a lead compound among a series of pyrrole derivatives with good in vitro activity against mycobacteria and candidae. Further studies led us to synthesize additional pyrroles bearing the thiomorpholinomethyl moiety and different aryl substituents at N1 and C5. Some of them revealed very active, prompting us to design the new pyrrole derivatives 5-20 in the hope of increasing the activity and better understanding the influence of ortho halogens on the antimycobacterial activity. Microbiological data showed interesting in vitro activity toward Mycobacterium tuberculosis and atypical mycobacteria.
|Appears in Collections:||Publications|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.